Contribution of voltage-gated potassium channels to the regulation of apoptosis

FEBS Letters

Volumn 584, Issue 10, 2010, Pages 2049-2056

  Szabò, Ildikò ^a   Zoratti, Mario ^b   Gulbins, Erich ^c  

^a UNIVERSITY OF PADOVA   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Apoptosis; Kv1.3; Mitochondria; Potassium channel; Pro apoptotic Bax

Indexed keywords

POTASSIUM CHANNEL KV1.3;

AMINO TERMINAL SEQUENCE; APOPTOSIS; CELL MEMBRANE POTENTIAL; CELL PROLIFERATION; CELL TYPE; DNA FRAGMENTATION; DOWN REGULATION; HUMAN; HYPERPOLARIZATION; LYMPHOCYTE; LYMPHOCYTE ACTIVATION; MITOCHONDRIAL MEMBRANE; NONHUMAN; POTASSIUM TRANSPORT; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; REGULATORY MECHANISM; REVIEW;

ANIMALS; APOPTOSIS; HUMANS; KV1.3 POTASSIUM CHANNEL; LYMPHOCYTES; MITOCHONDRIA; POTASSIUM CHANNELS, VOLTAGE-GATED;

EID: 77952671757     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2010.01.038     Document Type: Review

References (111)

1. Pongs O. Structure-function studies on the pore of potassium channels. J. Membr. Biol. 1993, 136:1-8.
2. Gutman G.A., Chandy K.G., Grissmer S., Lazdunski M., McKinnon D., Pardo L.A., Robertson G.A., Rudy B., Sanguinetti M.C., Stühmer W., Wang X. International Union of Pharmacology. LIII. Nomenclature and molecular relationships of voltage-gated potassium channels. Pharmacol. Rev. 2005, 57:473-508.
3. MacKinnon R., Yellen G. Mutations affecting TEA blockade and ion permeation in voltage-activated K+ channels. Science 1990, 250:276-279.
4. Yool A.J., Schwarz T.L. Alteration of ionic selectivity of a K+ channel by mutation of the H5 region. Nature 1991, 349:700-704.
5. Pardo L.A. Voltage-gated potassium channels in cell proliferation. Physiology (Bethesda) 2004, 19:285-292.
6. Lang F., Föller M., Lang K.S., Lang P.A., Ritter M., Gulbins E., Vereninov A., Huber S.M. Ion channels in cell proliferation and apoptotic cell death. J. Membr. Biol. 2005, 205:147-157.
7. Lang F., Ritter M., Gamper N., Huber S., Fillon S., Tanneur V., Lepple-Wienhues A., Szabo I., Gulbins E. Cell volume in the regulation of cell proliferation and apoptotic cell death. Cell Physiol. Biochem. 2000, 10:417-428.
8. Wang Z. Roles of K+ channels in regulating tumour cell proliferation and apoptosis. Pflugers Arch. Eur. J. Physiol. 2004, 448:274-286.
9. Arcangeli A., Crociani O., Lastraioli E., Masi A., Pillozzi S., Becchetti O. Targeting ion channels in cancer: a novel frontier in antineoplastic therapy. Curr. Med. Chem. 2009, 16:66-93.
10. Lang F., Foller M., Lang K., Lang P., Ritter M., Vereninov A., Szabò I., Huber S., Gulbins E. Cell volume regulatory ion channels in cell proliferation and cell death. Methods Enzymol. 2007, 428:209-225.
11. Lewis R.S. Calcium signalling mechanisms in T lymphocytes. Ann. Rev. Immunol. 2001, 19:497-521.
12. Cahalan M.D., Chandy K.G. The functional network of ion channels in lymphocytes. Immunol. Rev. 2009, 231:59-97.
13. Lang F., Gulbins E., Szabo I., Lepple-Wienhues A., Huber S.M., Duranton C., et al. Cell volume and the regulation of apoptotic cell death. J. Mol. Recognit. 2004, 17:473-480.
14. Bortner C.D., Cidlowski J.A. Cell shrinkage and monovalent cation fluxes: role in apoptosis. Arch. Biochem. Biophys. 2007, 462:176-188.
15. Burg E.D., Remillard C.V., Yuan J.X. Potassium channels in the regulation of pulmonary artery smooth muscle cell proliferation and apoptosis: pharmacotherapeutic implications. Br. J. Pharmacol. 2008, 153:S99-S111.
16. Yu S.P. Regulation and critical role of potassium homeostasis in apoptosis. Prog. Neurobiol. 2003, 70:363-386.
17. Dallaporta B., Marchetti P., de Pablo M.A., Maisse C., Duc H.T., Metivier D., et al. Plasma membrane potential in thymocyte apoptosis. J. Immunol. 1999, 162:6534-6542.
18. Okada Y., Maeno E. Apoptosis, cell volume regulation and volume regulatory chloride channels. Comp. Biochem. Physiol. A 2001, 130:377-383.
19. Szabo I., Lepple-Wienhues A., Kaba K.N., Zoratti M., Gulbins E., Lang F. Tyrosine kinase-dependent activation of a chloride channel in CD95-induced apoptosis in T lymphocytes. Proc. Natl. Acad. Sci. USA 1998, 95:6169-6174.
20. Lepple-Wienhues A.L., Szabò I., Laun T., Kaba N.K., Gulbins E., Fang F. The tyrosine kinase p56lck mediates activation of swelling-induced chloride channels in lymphocytes. J. Cell Biol. 1998, 141:281-286.
21. Maeno E., Ishizaki Y., Kanaseki T., Hazama A., Okada Y. Normotonic cell shrinkage because of disordered volume regulation is an early prerequisite to apoptosis. Proc. Natl. Acad. Sci. USA 2000, 97:9487-9492.
22. Yu S.P., Yeh C.H., Sensi S.L., Gwag B.J., Canzoniero L.M.T., Farhangrazi Z.S., Ying H.S., Tian M., Dugan L.L., Choi D.W. Mediation of neuronal apoptosis by enhancement of outward potassium current. Science 1997, 278:114-117.
23. Wang X., Xiao A.Y., Ichinose T., Yu S.P. Effects of tetraethylammonium analogs on apoptosis and membrane currents in cultured cortical neurons. J. Pharmacol. Exp. Ther. 2000, 295:524-530.
24. Wei L., Yu S.P., Gottron F., Snider B.J., Zipfel G.J., Choi D.W. Potassium channel blockers attenuate hypoxia- and ischemia-induced neuronal death in vitro and in vivo. Stroke 2003, 34:1281-1286.
25. Avdonin V., Kasuya J., Ciorba M.A., Kaplan B., Hoshi T., Iverson L. Apoptotic proteins Reaper and Grim induce stable inactivation in voltage-gated potassium channels. Proc. Natl. Acad. Sci. USA 1998, 95:11703-11708.
26. Chin L.S., Park C.C., Zitnay K.M., Sinha M., DiPatri A.J., Perillan P., Simard J.M. 4-Aminopyridine causes apoptosis and blocks an outward rectifier K+ channel in malignant astrocytoma cell lines. J. Neurosci. Res. 1997, 48:122-127.
27. Lauritzen I., De Weille J.R., Lazdunski M. The potassium channel opener cromakalim prevents glutamate-induced cell death in hippocampal neurons. J. Neurochem. 1997, 69:1570-1579.
28. Szabò I., Gulbins E., Apfel H., Zhang X., Barth P., Busch A.E., Schlottmann K., Pongs O., Lang F. Tyrosine-phosphorylation-dependent suppression of a voltage-gated K+ channel in T lymphocytes upon Fas stimulation. J. Biol. Chem. 1996, 271:20465-20469.
29. Bortner C.D., Hughes F.M., Cidlowski J.A. A primary role for K+ and Na+ efflux in the activation of apoptosis. J. Biol. Chem. 1997, 272:32436-32442.
30. Storey N.M., Gomez-Angelats M., Bortner C.D., Armstrong D.L., Cidlowski J.A. Stimulation of Kv1.3 potassium channels by death receptors during apoptosis in Jurkat T lymphocytes. J. Biol. Chem. 2003, 278:33319-33326.
31. Valencia-Cruz G., Shabala L., Delgado-Enciso I., Shabala S., Bonales-Alatorre E., Pottosin I.I., Dobrovinskaya O.R. Kbg and Kv1.3 channels mediate potassium efflux in the early phase of apoptosis in Jurkat T lymphocytes. Am.J. Cell. Physiol. 2009, 297:C1544-C1553.
32. Bock J., Szabò I., Jekle A., Gulbins E. Actinomycin Dinduced apoptosis involves the potassium channel Kv1.3. Biochem. Biophys. Res. Commun. 2002, 295:526-531.
33. Szabó I., Bock J., Grassmé H., Soddemann M., Wilker B., Lang F., Zoratti M., Gulbins E. Mitochondrial potassium channel Kv1.3 mediates Bax-induced apoptosis in lymphocytes. Proc. Natl. Acad. Sci. USA 2008, 105:14861-14866.
34. Hu C.L., Zeng X.M., Zhou M.H., Shi Y.T., Cao H., Mei Y.A. Kv1.1 is associated with neuronal apoptosis and modulated by protein kinase C in the rat cerebellar granule cell. J. Neurochem. 2008, 106:1125-1137.
35. Koeberle P.D., Wang Y., Schlichter L.C. Kv1.1 and Kv1.3 contribute to the degeneration of retinal ganglion cells after optic nerve transection in vivo. Cell Death Diff. 2009, 1-11.
36. Shen Q.J., Zhao Y.M., Cao D.X., Wang X.L. Contribution of Kv channel subunits to glutamate-induced apoptosis in cultured rat hippocampal neurons. J. Neurosci. Res. 2009, 87:3153-3160.
37. Lee A.L., Dumas T.C., Tarapore P.E., Webster B.R., Ho D.Y., Kaufer D., Sapolsky R.M. Potassium channel gene therapy can prevent neuron death resulting from necrotic and apoptotic insults. J. Neurochem. 2003, 86:1079-1088.
38. Yu S.P., Choi D.W. K+ efflux mediated by delayed rectifier K+ channels contributes of neuronal death. Alzheimer's disease and related disorders 1999, 371-382. John Wiley & Sons, New York. K. Iqbal, D.F. Swaab, B. Winblad, H.M. Wisniewski (Eds.).
39. Pal S., Hartnett K.A., Nerbonne J.M., Levitan E.S., Aizenman E. Mediation of neuronal apoptosis by Kv2.1-encoded potassium channels. J. Neurosci. 2003, 23:4798-4802.
40. Yuan X.J., Wang J., Juhaszova M., Gaine S.P., Rubin L.J. Attenuated K+ channel gene transcription in primary pulmonary hypertension. Lancet 1998, 351:726-727.
41. Brevnova E.E., Platoshyn O., Zhang S., Yuan J.X.-J. Overexpression of human KCNA5 increases IK(V) and enhances apoptosis. Am. J. Physiol. Cell Physiol. 2004, 287:C715-C722.
42. Krick S., Platoshyn O., McDaniel S.S., Rubin L.J., Yuan J.X.-J. Augmented K+ currents and mitochondrial membrane depolarization in artery myocyte apoptosis. Am. J. Physiol. Lung Cell Mol. Physiol. 2001, 281:L887-L894.
43. Caouette D., Dongmo C., Berube J., Fournier D., Daleau P. Hydrogen peroxide modulates the Kv1.5 channel expressed in a mammalian cell line. Naunyn Schmiedebergs Arch. Pharmacol. 2003, 368:479-486.
44. Michelakis E.D., Hampl V., Nsair A., Wu X., Harry G., Haromy A., Gurtu R., Archer S.L. Diversity in mitochondrial function explains differences in vascular oxygen sensing. Circ. Res. 2002, 90:1307-1315.
45. Duprat F., Guillemare E., Romey G., Fink M., Lesage F., Lazdunski M., Honore E. Susceptibility of cloned K+ channels to reactive oxygen species. PNAS USA 1995, 92:11796-11800.
46. Szabò I., Nilius B., Zhang X., Busch A.E., Gulbins E., Suessbrich H., Lang F. Inhibitory effects of oxidants on n-type K+ channel in T lymphocytes and in Xenopus oocytes. Pfluegers Arch. 2007, 433:626-632.
47. Cayabyab F.S., Khanna R., Jones O.T., Schlichter L.C. Suppression of the rat microglia Kv1.3 current by Src-family tyrosine kinases and oxygen/glucose deprivation. Eur. J. Neurosci. 2000, 12:1949-1960.
48. Wang H., Zhang Y., Cao L., Han H., Wang J., Yang B., Nattel S., Wang Z. HERG K+ channel, a regulator of tumor cell apoptosis and proliferation. Cancer Res. 2002, 62:4843-4848.
49. Thomas D., Bloehs R., Koschny R., Ficker E., Sykora J., Khien J., Schloemer K., et al. Doxasozin induces apoptosis of cells expressing hERG K+ channels. Eur. J. Pharm. 2008, 579:98-103.
50. Remillard C.V., Yuan J.X. Activation of K+ channels: an essential pathway in programmed cell death. Am. J. Physiol. Lung Cell Mol. Physiol. 2004, 286:L49-L67.
51. Alizadeh A.A., Eisen M.B., Davis R.E., Ma C., Lossos I.S., Rosenwald A., Boldrick J.C., Sabet H., Tran T., Yu X., et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 2000, 403:503-511.
52. Preussat K., Beetz C., Schrey M., Kraft R., Wölfl S., Kalff R., Patt S. Expression of voltage-gated potassium channels Kv 1.3 and Kv 1.5 in human gliomas. Neurosci. Lett. 2003, 346:33-36.
53. Abdul M., Santo A., Hoosein N. Activity of potassium channel blockers in breast cancer. Anticancer Res. 2003, 23:3347-3351.
54. Jang S.H., Kang K.S., Ryu P.D., Lee S.Y. Kv1.3 voltage-gated K+ channel subunit as potential diagnostic marker and therapeutic target for breast cancer. BMB Rep. 2009, 42:535-539.
55. Brevet M., Ahidouch A., Sevestre H., Merviel P., El Hiani Y., Robbe M., Ouadid-Ahidouch H. Expression of K+ channels in normal and cancerous human breast. Histol. Histopathol. 2008, 23:965-972.
56. Abdul M., Hoosein N. Reduced Kv 1.3 potassium channel expression in human prostate cancer. J. Membr. Biol. 2006, 214:99-102.
57. Abdul M., Hoosein N. Voltage-gated potassium ion channels in colon cancer. Oncol. Rep. 2002, 9:961-964.
58. Fiske J.L., Fomin V.P., Brown M.L., Duncan R.L., Sikes R.A. Voltage-sensitive ion channels and cancer. Cancer Metastasis Rev. 2006, 25:493-500.
59. Brevet M., Fucks D., Chatelain D., Regimbeau J.M., Delcenserie R., Sevestre H., Ouadid-Ahidouch H. Deregulation of 2 potassium channels in pancreas adenocarcinomas: implication of KV1.3 gene promoter methylation. Pancreas 2009, 38:649-654.
60. Chandy K.G., DeCoursey T.E., Cahalan M.D., McLaughlin C., Gupta S. Voltage-gated potassium channels are required for human T lymphocyte activation. J. Exp. Med. 1984, 160:369-385.
61. Chandy K.G., Wulff H., Beeton C., Pennington M., Gutman G.A., Cahalan M.D. K+ channels as targets for specific immunomodulation. Trends Pharmacol. Sci. 2004, 25:280-289.
62. Panyi G., Vámosi G., Bacsó Z., Bagdány M., Bodnár A., Varga Z., Gáspár R., Mátyus L., Damjanovich S. Kv1.3 potassium channels are localized in the immunological synapse formed between cytotoxic and target cells. Proc. Natl. Acad. Sci. USA 2004, 101:1285-1290.
63. Holmes T.C., Fadool D.A., Levitan I.B. Tyrosine phosphorylation of the Kv1.3 potassium channel. J. Neurosci. 1996, 16:1581-1590.
64. Gulbins E., Szabò I., Baltzer K., Lang F. Ceramide-induced inhibition of T lymphocyte voltage-gated potassium channel is mediated by tyrosine kinases. Proc. Natl. Acad. Sci. USA 1997, 94:7661-7666.
65. Schenck M., Carpinteiro A., Grassmé H., Lang F., Gulbins E. Ceramide: physiological and pathophysiological aspects. Arch. Biochem. Biophys. 2007, 462:171-175.
66. Detre C., Kiss E., Varga Z., Ludanyi K., Paszty K., Enyedi A., Kovesdi D., Panyi G., Rajnavolgyi E., Matko J. Death or survival: membrane ceramide controls the fate and activation of antigen-specific T cells depending on signal strength and duration. Cell. Signal. 2006, 18:294-306.
67. Deutsch C., Chen L.Q. Heterologous expression of specific K+ channels in T lymphocytes: functional consequences for volume regulation. Proc. Natl. Acad. Sci. USA 1993, 90:10036-10040.
68. Koni P.A., Khanna R., Chang M.C., Tang M.D., Kaczmarek L.K., Schlichter L.C., Flavell R.A. Compensatory anion currents in Kv1.3 channel-deficient thymocytes. J. Biol. Chem. 2003, 278:39443-39451.
69. Tafani M., Karpinich N.O., Serroni A., Russo M.A., Farber J.L. Re-evaluation of the distinction between type I and type II cells: the necessary role of the mitochondria in both the extrinsic and intrinsic signaling pathways upon Fas receptor activation. J. Cell. Physiol. 2006, 208:556-565.
70. Szabò I., Bock J., Jekle A., Soddemann M., Adams C., Lang F., Zoratti M., Gulbins E. A novel potassium channel in lymphocyte mitochondria. J.Biol.Chem. 2005, 280:12790-12798.
71. Spencer R.H., Sokolov Y., Li H., Takenaka B., Milici A.J., Aiyar J., Nguyen A., Park H., Jap B.K., Hall J.E., Gutman G.A., Chandy K.G. Purification, visualization, and biophysical characterization of Kv1.3 tetramers. J. Biol. Chem. 1997, 272:2389-2395.
72. Bednarczyk P. Potassium channels in brain mitochondria. Acta Biochim. Pol. 2009, 56:385-392.
73. Gulbins, E., Sassi, N., Grassmè, H., Zoratti, M. and Szabò, I. (2009) Role of Kv1.3 mitochondrial potassium channel in apoptotic signalling in lymphocytes. BBA Bioenerg. (in press).
74. Vicente R., Escalada A., Villalonga N., Texidó L., Roura-Ferrer M., Martín-Satué M., López-Iglesias C., Soler C., Solsona C., Tamkun M.M., Felipe A. Association of Kv1.5 and Kv1.3 contributes to the major voltage-dependent K+ channel in macrophages. J. Biol. Chem. 2006, 281:37675-37685.
75. Bonnet S., Archer S.L., Allalunis-Turner J., Haromy A., Beaulieu C., Thompson R., et al. A mitochondria-K+-channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell 2006, 11:37-51.
76. Annis M.G., Soucie E.L., Dlugosz P.J., Cruz-Aguado J.A., Penn L.Z., Leber B., Andrews D.W., et al. Bax forms multispanning monomers that oligomerize to permeabilize membranes during apoptosis. EMBO J. 2005, 24:2096-2103.
77. O'Rourke B., Cortassa S., Aon M.A. Mitochondrial ion channels: gatekeepers of life and death. Physiology 2005, 20:303-315.
78. Murphy M.P. How mitochondria produce reactive oxygen species. Biochem. J. 2009, 417:1-13.
79. Zoratti M., Szabò I. The mitochondrial permeability transition. Biochim. Biophys. Acta 1995, 1241:139-176.
80. Costantini P., Chernyak B.V., Petronilli V., Bernardi P. Modulation of the mitochondrial permeability transition pore by pyridine nucleotides and dithiol oxidation at two separate sites. J. Biol. Chem. 1996, 271:6746-6751.
81. Giorgio M., Migliaccio E., Orsini F., Paolucci D., Moroni M., Contursi C., Pelliccia G., Luzi L., Minucci S., Marcaccio M., Pinton P., Rizzuto R., Bernardi P., Paolucci F., Pelicci P.G. Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis. Cell 2005, 122:221-233.
82. Kumarswamy A., Chandna S. Putative partners in Bax-mediated cytochrome c release: ANT, CypD, VSAC or none of them?. Mitochondrion 2009, 9:1-8.
83. Scorrano L. Opening the doors to cytochrome c: changes in mitochondrial shape and apoptosis. Int. J. Biochem. Cell Biol. 2009, 41:1875-1883.
84. Ott M., Zhivotovsky B., Orrenius S. Role of cardiolipin in cytochrome c release from mitochondria. Cell Death Differ. 2007, 14:1243-1247.
85. Kagan V.E., Bayir H.A., Belikova N.A., Kapralov O., Tyurina Y.Y., Tyurin V.A., Jiang J., Stoyanovsky D.A., Wipf P., Kochanek P.M., Greenberger J.S., Pitt B., Shvedova A.A., Borisenko G. Cytochrome c/cardiolipin interactions in mitochondria: a kiss of death. Free Radic. Biol. Med. 2009, 46:1439-1453.
86. Hansson M.J., Morota S., Teilum M., Mattiasson G., Uchino H., Elmèr E. Increased potassium conductance of brain mitochondria induces resistance to permeability transition by enhancing matrix volume. J. Biol. Chem. 2010, 285:741-750.
87. Zhivotovsky B., Galluzzi L., Kepp O., Kroemer G. Adenine nucleotide translocase: a component of the phylogenetically conserved death machinery. Cell Death Diff. 2009, 16:1419-1426.
88. Perkins G., Bossy-Wetzel E., Ellisman M.H. New insights into mitochondrial structure during cell death. Exp. Neurol. 2009, 218:183-192.
89. Oakes S.A., Scorrano L., Opferman J.T., Bassik M.C., Nishino M., Pozzan T., Korsmeyer S.J. Proapoptotic BAX and BAK regulate the type 1 inositol trisphosphate receptor and calcium leak from the endoplasmic reticulum. Proc. Natl. Acad. Sci. USA 2005, 102:105-110.
90. Tsujimoto Y., Shimizu S. VDAC regulation by the Bcl-2 family of proteins. Cell Death Differ. 2000, 7:1174-1181.
91. Malia T.J., Wagner G. NMR structural investigation of the mitochondrial outer membrane protein VDAC and its interaction with antiapoptotic Bcl-xL. Biochemistry 2007, 46:514-525.
92. Cheng E.H., Sheiko T.V., Fisher J.K., Craigen W.J., Korsmeyer S.J. VDAC2 inhibits BAK activation and mitochondrial apoptosis. Science 2003, 301:513-517.
93. Jonas E.A. Molecular participants in mitochondrial cell death channel formation during neuronal ischemia. Exp. Neurol. 2009, 218:203-212.
94. Szewczyk A., Jarmuszkiewicz W., Kuncz W.S. Mitochondrial potassium channels. IUBMB Life 2009, 61:134-143.
95. Zoratti M., De Marchi U., Gulbins E., Szabò I. Novel channels of the inner mitochondrial membrane. Biochim. Biophys. Acta Bioenerg. 2009, 1787:351-363.
96. Bernardi P. Mitochondrial transport of cations: channels, exchangers, and permeability transition. Physiol. Rev. 1999, 79:1127-1155.
97. Garlid K., Paucek P. Mitochondrial potassium transport: the K+ cycle. Biochim. Biophys. Acta 2003, 1606:23-41.
98. Nowikowsky K., Schweyen R.J., Bernardi P. Pathophysiology of mitochondrial volume homeostasis: potassium transport and permeability transition. Biochim. Biophys. Acta Bioenerg. 2009, 1787(2009):345-350.
99. Inoue I., Nagase H., Kishi K., Higuti T. ATP-sensitive K+ channel in the mitochondrial inner membrane. Nature 1991, 352:244-247.
100. Siemen D., Loupatatzis C., Borecky J., Gulbins E., Lang F. Ca2+-activated K+ channel of the BK-type in the inner mitochondrial membrane of a human glioma cell line. Biochem. Biophys. Res. Commun. 1999, 257:549-554.
101. De Marchi U., Sassi N., Fioretti B., Catacuzzeno L., Cereghetti G.M., Szabò I., Zoratti M. Intermediate conductance Ca2+-activated potassium channel (Kca3.1) in the inner mitochondrial membrane of human colon cancer cells. Cell Calcium 2009, 45:509-516.
102. Rusznak Z., Bakondi G., Kosztka L., Pocsai K., Diens B., Fodor J., Telek A., Gomczi M., Szucs G., Csernoch L. Mitochondrial expression of the two-pore domain TASK-3 channels in malignantly transformed and non-malignant human cells. Virchows Arch. 2008, 452:415-426.
103. Sassi, N., De Marchi, U., Fioretti, B., Biasutto, L., Gulbins, E., Francolini, F., Szabò, I. and Zoratti, M. (2009) An investigation of the occurrence and properties of the mitochondrial intermediate-conductance Ca2+-activated K+ channel mtKCa3.1. BBA Bioenerg., doi:10.1016/j.bbabio.2009.12.015.
104. Bock J., Szabò I., Gamper N., Adams C., Gulbins E. Ceramide inhibits the potassium channel Kv1.3 by the formation of membrane platform. Biochem. Biophys. Res. Commun. 2003, 305:890-897.
105. Smart E.J., Ying Y.S., Conrad P.A., Anderson R.G. Caveolin moves from caveolae to the Golgi apparatus in response to cholesterol oxidation. J. Cell Biol. 1994, 127:1185-1197.
106. Conrad P.A., Smart E.J., Ying Y.S., Anderson R.G., Bloom G.S. Caveolin cycles between plasma membrane caveolae and the Golgi complex by microtubule-dependent and microtubule-independent steps. J. Cell Biol. 1995, 131:1421-1433.
107. Pelkmans L., Brli T., Zerial M., Helenius A. Caveolin-stabilized membrane domains as multifunctional transport and sorting devices in endocytic membrane traffic. Cell 2004, 118:767-780.
108. Pelkmans L. Secrets of caveolae- and lipid raft-mediated endocytosis revealed by mammalian viruses. Biochim. Biophys. Acta 2005, 1746:295-304.
109. Rizzuto R., Pinton P., Carrington W., Fay F.S., Fogarty K.E., Lifshitz L.M., Tuft R.A., Pozzan T. Close contacts with the endoplasmic reticulum as determinants of mitochondrial Ca2+ responses. Science 1998, 280:1763-1766.
110. Villarejo A., Burén S., Larsson S., Déjardin A., Monné M., Rudhe C., Karlsson J., Jansson S., Lerouge P., Rolland N., von Heijne G., Grebe M., Bako L., Samuelsson G., et al. Evidence for a protein transported through the secretory pathway en route to the higher plant chloroplast. Nat. Cell Biol. 2005, 7:1224-1231.
111. Balss J., Papatheodorou P., Mehmel M., Baumeister D., Hertel B., Delaroque N., Chatelain F.C., Minor D.L., Van Etten J.L., Rassow J., Moroni A., Thiel G. Transmembrane domain length of viral K+ channels is a signal for mitochondria targeting. Proc. Natl. Acad. Sci. USA 2008, 105:12313-12318.